MAPK3 and depressive symptom measurement: Animal studies confirm these findings, and drugs such as fluoxetine or ketamine normalize ERK1/2 levels in depression models (Qi et al. 2008; First et al. 2011; Li et al. 2010; Zhou et al. 2014; Miller et al. 2014; Ma et al. 2017; Lee et al. 2019).